FBXL2 and non-small cell lung carcinoma: As shown in Supplementary Fig. 5b, c, while FBXL2 effectively inhibited EGFR expression, it had little effects on ERK activation or cell proliferation of A549 or H1299 cells, indicating that EGFR signaling is responsible for the effects of FBXL2 on NSCLC growth.